Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
_Cancer Research Journal - This journal ceased publication after 4#4 (2010). Back Issues are available.
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Hepatitis C and Liver Transplantation
Tell A Friend
Tell someone you know about this product.
Hepatitis C and Liver Transplantation
Retail Price: $280.00
10% Online Discount
You Pay:

Editors: Sandeep Mukherjee (University of Nebraska Medical Center, Omaha, NE, USA)
Book Description:
This book provides a single reference for all transplant professionals involved in the care of HCV patients who have unique problems not encountered in other liver transplant patients. In the liver transplant community, it is well-known that decompensated cirrhosis from hepatitis C virus (HCV) is the leading indication for orthotopic liver transplantation (OLT) in the United States and most Western countries. Short-term results which initially seemed promising and comparable to other carefully selected liver transplant recipients now appear less encouraging with cirrhosis developing in 10-25% of patients by 5 years. Despite these concerns, there is an increased amount of data which supports re-transplantation in carefully selected patients.

We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:

Part I

Chapter 1. Epidemiology and burden of hepatitis C in the United States;pp. 1-11
(Miriam J. Alter, University of Texas Medical Branch, Galveston, Texas, USA)

Chapter 2. State of the art treatment of Hepatitis C;pp. 13-27
(Hans L. Tilmann, Alex Thompson, Keyur Patel, Duke University, Durham, North Carolina, USA)

Chapter 3. Beyond interferon and ribavirin-novel antiviral therapies for chronic Hepatitis C;pp. 29-44
(Rudolf E. Stauber, Medical University of Graz, Austria)

Chapter 4. Antiviral therapy for decompensated Hepatitis C-related cirrhosis before liver transplantation;pp. 45-53
(Bruno Roche, Didier Samuel, Univ Paris-Sud, Villejuif, France)

Part II

Chapter 5. Impact of preservation injury and donor factors on Hepatitis C recurrence after liver transplantation;pp. 57-76
(Stephen C Rayhill, Oregon Health Sciences University, Oregon, Portland, Oregon, USA)


Chapter 6. The natural history of recurrent Hepatitis C following liver transplantation;pp. 79-96
(Ed Gane, Auckland Hospital, Auckland, New Zealand)

Chapter 7. Mechanisms of liver injury from recurrent Hepatitis C;pp. 97-114
(Ulrich Spengler, Jacob Nattermann, University of Bonn, Bonn, Germany

Chapter 8. Hepatitis C and living donor liver transplantation;pp. 115-125
(Alexander Kuo, University of California San Diego, San Diego, California, USA and Norah A. Terrault, University of California San Francisco, San Francisco, California, USA)

Chapter 9. A logical approach to the use of immunosuppression in liver transplantation for hepatitis C virus;pp. 127-137
(James Neuberger, Queen Elizabeth Hospital, Birmingham, England)

Chapter 10. Differentiation of recurrent Hepatitis C virus from hepatic allograft rejection;pp. 139-153
(Lisa R. Dixon, Roniel Cabrera, University of Florida, Gainesville, Florida, USA)

Chapter 11. Monitoring hepatic fibrosis from Hepatitis C recurrence after liver transplantation;pp. 155-168
(Marina Berenguer, University of Valencia, Valencia, Spain)

Chapter 12. A systematic review of prophylactic anti-viral therapy for patients undergoing liver transplantation for chronic Hepatitis C;pp. 169-182
(Kurinchi S. Gurusamy, Andrew K. Burroughs, Brian R. Davidson, Royal Free Hospital and University College School of Medicine, London, England)

Chapter 13. A systematic review of anti-viral therapy for recurrent Hepatitis C after liver transplantation;pp. 183-200
(Kurinchi S. Gurusamy, Andrew K. Burroughs, Brian R. Davidson)

Chapter 14. Hepatitis C and liver retransplantation;pp. 201-216
(Hanna Kraus, Lisa Forman, University of Colorado Health Sciences Center, Denver, Colorado, USA)

Chapter 15. Evaluation and outcomes of liver transplantation for Hepatitis and HIV co-infection;pp. 217-228
(Ishfaq Bhat, Sandeep Mukherjee, University of Nebraska Medical Center, Omaha, Nebraska, USA)

Chapter 16. Quality of life after liver transplantation for Hepatitis C;pp. 229-244
(Jillian B. Kallman, Zobair M. Younossi, Nova Fairfax Hospital, Virginia, USA)

Chapter 17. Pediatric liver transplantation for Hepatitis C;pp. 245-259
(Jacfranz J. Guiteau, Ronald T. Cotton, Saul J. Karpen, Christine A. O’Mahony, John A. Goss, Baylor College of Medicine, Houston, Texas, USA)


      Hepatology Research and Clinical Developments
   Binding: Hardcover
   Pub. Date: 2011
   Pages: 7 x 10, 273 pp.
   ISBN: 978-1-61728-616-2
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Hepatitis C and Liver Transplantation